234 related articles for article (PubMed ID: 22902510)
1. Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin.
Zhao H; Yang Z; Wang X; Zhang X; Wang M; Wang Y; Mei Q; Wang Z
Exp Mol Med; 2012 Nov; 44(11):633-41. PubMed ID: 22902510
[TBL] [Abstract][Full Text] [Related]
2. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.
Deng QD; Lei XP; Zhong YH; Chen MS; Ke YY; Li Z; Chen J; Huang LJ; Zhang Y; Liang L; Lin ZX; Liu Q; Li SP; Yu XY
Acta Pharmacol Sin; 2021 Sep; 42(9):1486-1497. PubMed ID: 33893396
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro.
Hu H; Zhu S; Tong Y; Huang G; Tan B; Yang L
Anticancer Drugs; 2020 Jun; 31(5):483-491. PubMed ID: 31972592
[TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway.
Yuan S; Wang L; Chen X; Fan B; Yuan Q; Zhang H; Yang D; Wang S
Biomed Pharmacother; 2016 Dec; 84():1776-1782. PubMed ID: 27847199
[TBL] [Abstract][Full Text] [Related]
5. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
6. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling.
Wang H; Ma D; Wang C; Zhao S; Liu C
Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780
[TBL] [Abstract][Full Text] [Related]
7. Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.
Johnson SM; Wang X; Evers BM
J Surg Res; 2011 Jun; 168(2):197-205. PubMed ID: 19922946
[TBL] [Abstract][Full Text] [Related]
8. Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.
Wang J; Zhang Z; Li R; Sun W; Chen J; Zhang H; Shu K; Lei T
Life Sci; 2018 Feb; 194():150-156. PubMed ID: 29288766
[TBL] [Abstract][Full Text] [Related]
9. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
[TBL] [Abstract][Full Text] [Related]
10. Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis.
Reno TA; Kim JY; Raz DJ
Ann Thorac Surg; 2015 Nov; 100(5):1817-24; discussion 1824-5. PubMed ID: 26298168
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer.
Wang Y; Liu T; Li H
J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the migration and invasion is mediated by triptolide in B16F10 mouse melanoma cells through the NF-kappaB-dependent pathway.
Jao HY; Yu FS; Yu CS; Chang SJ; Liu KC; Liao CL; Ji BC; Bau DT; Chung JG
Environ Toxicol; 2016 Dec; 31(12):1974-1984. PubMed ID: 26420756
[TBL] [Abstract][Full Text] [Related]
13. Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines.
Liu Y; Cui YF
Asian Pac J Cancer Prev; 2013; 14(9):5243-8. PubMed ID: 24175808
[TBL] [Abstract][Full Text] [Related]
14. Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis.
Hu H; Huang G; Wang H; Li X; Wang X; Feng Y; Tan B; Chen T
Oncol Rep; 2018 Mar; 39(3):1191-1196. PubMed ID: 29286149
[TBL] [Abstract][Full Text] [Related]
15. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
16. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
[TBL] [Abstract][Full Text] [Related]
17. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.
Zhou H; Guo W; Long C; Wang H; Wang J; Sun X
Biochem Biophys Res Commun; 2015 Jan; 456(3):815-20. PubMed ID: 25511707
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
20. Role of triptolide as an adjunct chemotherapy for ovarian cancer.
Westfall SD; Nilsson EE; Skinner MK
Chemotherapy; 2008; 54(1):67-76. PubMed ID: 18073474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]